Bio Pharma Dive
NOVEMBER 4, 2020
Results the company will present at a medical meeting, while early, don't appear to meet the high bar set by rival CAR-T cell therapies from Bristol Myers Squibb and Johnson & Johnson.
World of DTC Marketing
NOVEMBER 4, 2020
THE SHORT : The confusion around the Presidential election, which is ongoing at the time of this post, has a lot of similarities with online health information. As social media becomes a bigger part of information gathering for health seekers they are often making bad treatment decisions based on what they read. According to Annual Review “in general, we do not have the cognitive capacity, motivation, or time to evaluate all the information that we encounter online.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
NOVEMBER 4, 2020
Documents made public ahead of a key advisory meeting Friday revealed an FDA more willing than expected to accept Biogen's controversial case for approval of aducanumab.
Pharma Mirror
NOVEMBER 4, 2020
To date, breast cancer is one of the most dangerous diseases. Unfortunately, it is not always possible to diagnose it early due to the lack of modern equipment in many countries. Medical tourism is getting popular, and you can easily get stage 4 breast cancer treatment in Germany. Modern hospitals in Germany have the most. The post Stage 4 Breast Cancer Treatment in Germany appeared first on Pharma Mirror Magazine.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
NOVEMBER 4, 2020
Professor Jean-Pierre Boissel outlines the urgent need for disruptive R&D approaches that can tackle the search for COVID-19 treatments more effectively. It may not be appropriate to use the word ‘failure’ when summarising the utility of clinical trials in the search for a curative or preventative treatment for disease. For the purposes of this text, let us assume that ‘success’ and ‘failure’ will be used in reference to the objective of clinical trial designers: to obtain sufficient evidenc
BioSpace
NOVEMBER 4, 2020
Abbott is suing their former VP Jerome Clavel over allegations of trade secret theft with intent to share with his new employer, rival diagnostics company Bio-Rad.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
NOVEMBER 4, 2020
South San Francisco-based Allogene Therapeutics released some early data from its Phase I UNIVERSAL clinical trial of ALLO-715 for relapsed/refractory multiple myeloma.
Scienmag
NOVEMBER 4, 2020
Scientists at Swansea University have developed a very sensitive method to detect the tiny signatures of so called ‘charge traps’ in organic semiconductors Credit: Swansea University Scientists at Swansea University have developed a very sensitive method to detect the tiny signatures of so called ‘charge traps’ in organic semiconductors.
BioSpace
NOVEMBER 4, 2020
When it comes to a novel virus like SARS-CoV2, a certain amount of “rolling with the punches” is required, and governments and global organizations like the World Health Organization are beginning to dismiss certain treatments and devote themselves wholeheartedly to others.
Scienmag
NOVEMBER 4, 2020
The center complements other NIH centers at SLAC and elsewhere that broaden access to this cutting-edge technology for biomedical research Credit: Jesús G. Galaz-Montoya and Kirk Czymmek The National Institutes of Health is establishing a national service center at the DOE’s SLAC National Accelerator Laboratory and Stanford University where biomedical researchers can learn how to […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
NOVEMBER 4, 2020
Novartis’ injectable migraine prevention antibody Aimovig has been shown to be more effective than topiramate – a go-to oral therapy for people with chronic migraine – in a head-to-head trial. The HER-MES trial found that Aimovig (erenumab) was more effective at preventing migraine attacks and also better tolerated than topiramate, a generic epilepsy drug which is known to have side effects like sleepiness, dizziness, diarrhoea and nausea.
Scienmag
NOVEMBER 4, 2020
New radar satellites allow observation in almost real time Credit: Wei Tang, Mahdi Motagh, Wei Zhan When it comes to safety in open-cast mining, soil stability is one of the most critical factors. Settlement of the ground or slipping of slopes poses a great risk to buildings and people. Now Mahdi Motagh from the German […].
pharmaphorum
NOVEMBER 4, 2020
Ireland-based Fountain Healthcare Partners has raised another €125 million ($131 million) for its third life sciences fund – 25% ahead of its target – and says it will pump most of the money into European therapeutics and medical device companies. The latest cash injection adds to the €118 million initially raised by Fountain Healthcare for the fund in May 2019, and brings the total value managed by the company above the €300 million mark.
Scienmag
NOVEMBER 4, 2020
Credit: NIAID-RML The majority of people infected with SARS-CoV-2 appear to actively shed infectious virus for about 8 days, but there is a wide range of variability from person to person. Understanding how long people can remain actively infected is important, because it provides new details about a disease and a virus that are still […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Outsourcing Pharma
NOVEMBER 4, 2020
The agency has chosen Continuity Pharma to aid in development and advancement of continuous manufacturing technology, with the help of a $1.5m grant.
Scienmag
NOVEMBER 4, 2020
The 5-year 8M € project GAIN4CROPS aims to improve photosynthetic efficiency of the oil crop sunflower using nature-inspired solutions and innovative breeding techniques. Credit: Photo by Sirr Snow on Unsplash GAIN4CROPS is developing novel disruptive technologies to overcome one of the main constraints of photosynthesis: the photorespiration, a process that reduces CO2 assimilation efficiency, and […].
BioSpace
NOVEMBER 4, 2020
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
Scienmag
NOVEMBER 4, 2020
Large-diameter trees make up 3% of total stems, but account for 42% of total carbon storage in Pacific Northwest forest ecosystems Credit: The authors Older, large-diameter trees have been shown to store disproportionally massive amounts of carbon compared to smaller trees, highlighting their importance in mitigating climate change, according to a new study in Frontiers […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Outsourcing Pharma
NOVEMBER 4, 2020
According to representatives from the pharma solutions provider, incorporation of CM processes, after a slow period, is expanding across the industry.
Scienmag
NOVEMBER 4, 2020
Stopping emerging viruses could depend on getting T cells and antibodies to work together Credit: NIAID LA JOLLA–Where Aedes mosquitoes fly, Zika virus may not be far behind. Although the explosive 2015-2016 Zika epidemics in the Americas are behind us, Zika may re-emerge, and “in many countries, Zika may be spreading in silence,” says Sujan […].
BioSpace
NOVEMBER 4, 2020
The Healthcare Technology Report announced on Nov. 3 its list of the Top 25 Women Leaders in Biotechnology of 2020.
Scienmag
NOVEMBER 4, 2020
Sandia computer scientist also bestowed Professional Achievement Award Credit: Photo by Randy Montoya ALBUQUERQUE, N.M. — Sandia National Laboratories has been named 2020 Organization of the Year in the government category by the Society of Asian Scientists and Engineers. The award, presented during the society’s virtual conference this month, recognizes organizations with a longstanding commitment […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
BioSpace
NOVEMBER 4, 2020
According to recent polls, less than half of Americans trust pharmaceutical companies. In fact, only 42% of respondents say they have any trust in pharma, with a paltry 6% having a great deal.
Scienmag
NOVEMBER 4, 2020
Researchers from Nara Institute of Science and Technology find that the plant hormone ethylene mediates the invasion of hosts by parasitic plants Credit: Satoko Yoshida Nara, Japan – Mutants that reveal the secrets of how plants attack? No, it’s not a scene from a science fiction movie, but you could be forgiven for thinking that. […].
BioPharma Reporter
NOVEMBER 4, 2020
While all eyes are on a certain top job in the US at the moment, the biopharmaceutical industry is also looking at its leaders.
Scienmag
NOVEMBER 4, 2020
Credit: (C) Turning Point A recent study has shown that it may be possible to dampen the workings of the subconscious brain to prevent alcohol relapse, the results leading to a world-first trial of a personalised smartphone app called “SWiPE” Cognitive Bias Modification, a new form of computerised brain-training, is focused on training the brain […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioSpace
NOVEMBER 4, 2020
It’s a busy time of year for the biopharma industry, as most companies have begun reporting third-quarter financials.
Scienmag
NOVEMBER 4, 2020
Credit: University of Rochester illustration / Michael Osadciw Researchers at the University of Rochester and Cornell University have taken an important step toward developing a communications network that exchanges information across long distances by using photons, mass-less measures of light that are key elements of quantum computing and quantum communications systems.
BioSpace
NOVEMBER 4, 2020
The company announced late Wednesday that its sickle cell disease gene therapy treatment will not be submitted to the U.S. Food and Drug Administration for two more years.
Scienmag
NOVEMBER 4, 2020
Credit: Credit: Raul Martin The first fossils of a duckbilled dinosaur have been discovered in Africa, suggesting dinosaurs crossed hundreds of kilometres of open water to get there. The study, published in Cretaceous Research, reports the new dinosaur, Ajnabia odysseus, from rocks in Morocco dating to the end of the Cretaceous, 66 million years ago. […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
350 
Let's personalize your content